Cellectis
CLLS
#7374
Rank
NZ$0.78 B
Marketcap
NZ$7.68
Share price
-1.79%
Change (1 day)
123.00%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: NZ$0.78 Billion

As of January 2026 Cellectis has a market cap of NZ$0.78 Billion. This makes Cellectis the world's 7374th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.78 B-4.69%
2025NZ$0.82 B222.61%
2024NZ$0.25 B-26.84%
2023NZ$0.34 B126.18%
2022NZ$0.15 B-72.52%
2021NZ$0.56 B-68.26%
2020NZ$1.76 B59.56%
2019NZ$1.10 B1.5%
2018NZ$1.09 B-23.12%
2017NZ$1.41 B62.36%
2016NZ$0.87 B-44.29%
2015NZ$1.56 B180.71%
2014NZ$0.55 B585.97%
2013NZ$81.48 M

End of Day market cap according to different sources

On Jan 8th, 2026 the market cap of Cellectis was reported to be:

NZ$0.56 Billion
by Nasdaq info icon info icon
NZ$0.79 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
uniQure
QURE
NZ$2.78 B 255.39%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
NZ$2.08 B 165.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$146.75 B 18,613.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
NZ$0.80 B 2.12%๐Ÿ‡บ๐Ÿ‡ธ USA